Venkatesan Aranapakam

Independent Researcher

Publications

166

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies

N. Rao, Sanjeeva P. Reddy, G. Sandeep, N. Damle, V. Aranapakam - Unknown Venue, 2015

Cited by 3 Semantic Scholar

Synthesis and Structure−Activity Relationship of N-Substituted 4-Arylsulfonylpiperidine-4-hydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis

V. Aranapakam, J. Davis, G. Grosu, J. Baker, J. Ellingboe - Unknown Venue, 2003

Cited by 62 Semantic Scholar

Synthesis and Structure−Activity Relationship of α-Sulfonylhydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis

V. Aranapakam, G. Grosu, J. Davis, Baihua Hu, J. Ellingboe - Unknown Venue, 2003

Cited by 59 Semantic Scholar

5-fluoro-2-methyl-N-[5-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-yl carbonyl)-2-pyridinyl]benzamide (CL-385004) and analogs as orally active arginine vasopressin receptor antagonists.

V. Aranapakam, J. Albright, G. Grosu, Efren Delos Santos, Peter S. Chan - Bioorganic & Medicinal Chemistry Letters, 1999

Cited by 20 Semantic Scholar

4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists.

V. Aranapakam, J. Albright, G. Grosu, P. Chan, J. Coupet - Bioorganic & Medicinal Chemistry Letters, 1999

Cited by 12 Semantic Scholar

5‐Fluoro‐2‐methyl‐N‐[5‐(5H‐pyrrolo[2,1‐c][1,4]benzodiazepine‐10(11H)‐yl carbonyl)‐2‐pyridinyl]benzamide (CL‐385004) and Analogues as Orally Active Arginine Vasopressin Receptor Antagonists.

V. Aranapakam, J. Albright, G. Grosu, E. D. Santos, P. Chan - Unknown Venue, 1999

Cited by 0 Semantic Scholar

Research Topics

Neuroendocrine regulation and behavior (3) Anesthesia and Sedative Agents (2) Protease and Inhibitor Mechanisms (2) Electrolyte and hormonal disorders (2) Chemical Reaction Mechanisms (2)

Affiliations

Pearl River Community College

US 1999 - 1999

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Venkatesan Aranapakam

Publication & Citation Trends

Publications

ASN002: A Potent Dual SYK/JAK Inhibitor Currently in a Phase I/II Study Shows Strong Antitumor Activity in Preclinical Studies

Synthesis and Structure−Activity Relationship of N-Substituted 4-Arylsulfonylpiperidine-4-hydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis

Synthesis and Structure−Activity Relationship of α-Sulfonylhydroxamic Acids as Novel, Orally Active Matrix Metalloproteinase Inhibitors for the Treatment of Osteoarthritis

5-fluoro-2-methyl-N-[5-(5H-pyrrolo[2,1-c][1,4]benzodiazepine-10(11H)-yl carbonyl)-2-pyridinyl]benzamide (CL-385004) and analogs as orally active arginine vasopressin receptor antagonists.

4,10-dihydro-5H-thieno[3,2-c][1]benzazepine derivatives and 9,10-dihydro-4H-thieno[2,3-c][1]benzazepine derivatives as orally active arginine vasopressin receptor antagonists.

5‐Fluoro‐2‐methyl‐N‐[5‐(5H‐pyrrolo[2,1‐c][1,4]benzodiazepine‐10(11H)‐yl carbonyl)‐2‐pyridinyl]benzamide (CL‐385004) and Analogues as Orally Active Arginine Vasopressin Receptor Antagonists.

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back